Owl Creek Asset Management’s TriSalus Life Sciences TLSI Stock Holding History

Owl Creek Asset Management’s Portfolio TLSI Stock Details TLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-39,999	Closed	-$392K	–	416
2022 Q1	$392K	Hold	39,999	–	–	0.02%	171
2021 Q4	$395K	Hold	39,999	–	–	0.03%	208
2021 Q3	$397K	Hold	39,999	–	–	0.02%	202
2021 Q2	$388K	Hold	39,999	–	–	0.02%	204
2021 Q1	$386K	Buy	+39,999	New	+$406K	0.01%	186

Other funds holding TLSI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

IPCP

Iron Park Capital Partners New York $621K AUM 73.14% 1-Year Est. Return

Owl Creek Asset Management's TLSI Position: Q2 2022 in Review

Owl Creek Asset Management sold out of TriSalus Life Sciences (TLSI) in Q2 2022, closing a stake of 39,999 shares — an estimated $392K sold.

Owl Creek Asset Management first reported a position in TLSI in Q1 2021 and held it in 5 quarters. The position peaked at $397K in Q3 2021. 72 funds tracked by Wall St. Rank hold TLSI as of Q2 2022.

Owl Creek Asset Management reported no remaining TriSalus Life Sciences position as of Q2 2022 after selling out during the quarter.
Owl Creek Asset Management sold 39,999 TriSalus Life Sciences shares in Q2 2022, an estimated $392K.
Owl Creek Asset Management first reported a position in TriSalus Life Sciences in Q1 2021 and held it in 5 quarters.
Owl Creek Asset Management's TriSalus Life Sciences position peaked at $397K in Q3 2021.
72 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q2 2022.

Based on Owl Creek Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.